A survey assessing women’s awareness of breast cancer overdiagnosis and overtreatment demonstrated low awareness surrounding the main potential harmful effects of screening.
NICE has announced that the immunotherapy nivolumab will now be made available on the Cancer Drugs Fund for treating locally advanced or metastatic squamous and non-squamous non-small-cell lung cancers after prior chemotherapy.
One of Britain’s biggest privately owned biotech companies is set to secure additional funding which could propel its progress in developing novel immunotherapies.
Handheld instrument identifies cancerous tissue during surgery, providing surgeons with accurate diagnostic information about what tissue to cut or preserve.
A nationwide study across Ireland revealed that the vast majority of patients do not understand the core concepts underpinning a clinical trial.
Results from two international clinical trials yield promising results for halting the mestatise of melanoma, yield novel treatment options for melanoma and may help stop this form of cancer metastizing.
Recent research demonstrates that the ratio of abdominal fat to peripheral fat is a significant independent predictor of cancer.
A recent clinical trial presents new data indicating durvalumab improves progression-free survival in patients with stage III non-small-cell lung cancer (NSCLC).
Patients with rare cancers who are not able to receive standard treatment may be able to receive existing therapies designed for different cancers with the same genetic mutations, according to a novel study.
Drugs used to treat heart and blood vessel problems have shown promise in combination with chemotherapy for acute myeloid leukemia treatment.